Live Chat

Perdagangan Vir Biotechnology VIR

Jual
 Beli

VirBiotechnology diagram langsung

5m 15m 30m 1h 4h 1d 1w

Dasar-dasar Instrumen

Weekly Search
Weekly
Daily
Tanggal Tutup Ubah Ubah (%) Buka Tinggi Rendah

Berita

Info

Spread

0.05

Spread (%)

0.6562 %

Leverage

1:10

Bunga Overnight Beli

-0.0597 %

Bunga Overnight Jual

-0.0292 %

Mata Uang

USD

Jam Trading

Pasar tutup

Senin

13:31 - 19:59

Selasa

13:31-19:59

Rabu

13:31-19:59

Kamis

13:31-19:59

Jumat

13:31-19:59

Analisis dan Statistik

Buka

---

Sebelumnya Tutup

---

52 Minggu Tigg/Rdh

--- – ---

Kapitalisasi Pasar

1317845888

Saham yang Beredar

136706000

Tanggal Penghasilan (Berikutnya)

0000-00-00

Hasil Div

Tanggal Non-Dividen

Proyeksi tingkat dividen tahunan

0

Proyeksi hasil dividen tahunan

0

EPS

-3.58

Pelajari lebih lanjut tentang instrumen ini

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California.

Instrumen Terkait

Aset
Jual
Beli
Ubah (%)

Lakukan Trading

Lakukan Trading

Lakukan Trading

Lakukan Trading
view_all_instruments

Berita Terkini

Ikuti terus berita keuangan terkini dari seluruh dunia.

Rabu, 6 November 2024

U.S. presidential election market volatility drives Bitcoin prices to reach a historic high

Stock market rally

Selasa, 5 November 2024

US Election Results Trigger Stock Gains Across Europe, Asia, and US

US Election Trump's victory

Selasa, 5 November 2024

Trump Victory Spurs Market Gains and Economic Shift Expectations

Selasa, 5 November 2024

US election: bitcoin price (BTC) surged to new record as Trump leading ahead

Selasa, 5 November 2024

Stock Market Today: Wall Street Rallies on Election Day Amid Strong Economic Outlook

US Election 2024 Trump

Selasa, 5 November 2024

Early Election Results Shift Markets as Trump’s Chances Rise

Senin, 4 November 2024

Stock Market Today: S&P 500 Declines as Investors Brace for US Election

Senin, 4 November 2024

US election: What will happen to tesla stock if Trump wins?

Lihat semua berita
Trustpilot
Live Chat